-
Mashup Score: 1Y Chromosome Loss in Cancer Drives Growth by Evasion of Adaptive Immunity - Beyond the Abstract - 14 day(s) ago
IMvigor210 atezolizumab (anti-PD-L1) clinical trial, muscle invasive bladder cancer (MIBC), Y Chromosome Loss in Cancer, loss of the Y chromosome (LOY), loss of the Y chromosome in blood leukocytes, CRISPR-mediated deletion, immune checkpoint blockade therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?- Beyond the Abstract - 21 day(s) ago
bladder cancer, Genitourinary Cancers, lymph node dissection (LND), Extended Pelvic Lymph Node Dissection (EPLND), Inguinal Lymph Node Dissection (ILND), SWOG S1011 trial, InPACT trial, kidney cancer, upper tract urothelial carcinoma, prostate cancer, penile cancer.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Delve into the contemporary role of Lymph Node Dissection (LND) in GU cancers! This collaborative review covers bladder, UTUC, kidney, prostate, and penile cancer, offering evidence-based recommendations and insights. #ReadNow on UroToday > https://t.co/b9vVaPXaS1 @AmandaMyersMD https://t.co/aByGPw617J
-
-
Mashup Score: 1Y Chromosome Loss in Cancer Drives Growth by Evasion of Adaptive Immunity - Beyond the Abstract - 1 month(s) ago
IMvigor210 atezolizumab (anti-PD-L1) clinical trial, muscle invasive bladder cancer (MIBC), Y Chromosome Loss in Cancer, loss of the Y chromosome (LOY), loss of the Y chromosome in blood leukocytes, CRISPR-mediated deletion, immune checkpoint blockade therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Y Chromosome Loss in Cancer Drives Growth by Evasion of Adaptive Immunity - Beyond the Abstract - 2 month(s) ago
IMvigor210 atezolizumab (anti-PD-L1) clinical trial, muscle invasive bladder cancer (MIBC), Y Chromosome Loss in Cancer, loss of the Y chromosome (LOY), loss of the Y chromosome in blood leukocytes, CRISPR-mediated deletion, immune checkpoint blockade therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6Pangea Laboratory Receives FDA Breakthrough Device Designation for the Bladder CARE™ Assay - 3 month(s) ago
Bladder CARE™ Assay, non-invasive Bladder CARE™ Assay, bladder cancer, upper tract urothelial carcinoma (UTUC), urothelial cancer-specific DNA biomarkers, Pangea Laboratory.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Neurogenic Lower Urinary Tract Dysfunction - Beyond the Abstract - 5 month(s) ago
neurogenic lower urinary tract dysfunction (NLUTD), clean intermittent catheterization (CIC), Urologic Management to Preserve Initial Renal Function (UMPIRE), management of children with NLUTD.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
Prostate Cancer, MRI-visible localized prostate cancer, Radical Prostatectomy, Risk for Adverse Pathology Radical Prostatectomy, Partial Gland Ablation, MRI-visible localized prostate cancer, men eligible for partial gland ablation but underwent radical prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1The Role of Epitranscriptomic Regulator NAT10 in Bladder Cancer Chemoresistance - Expert Commentary - 5 month(s) ago
bladder cancer, Epitranscriptomic Regulator NAT10, Epitranscriptomic Regulator NAT10 in Bladder Cancer Chemoresistance, epithelial-to-mesenchymal (EMT), Post-transcriptional RNA modifications, AHNAK, NF-kB pathway.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study - Beyond the Abstract - 5 month(s) ago
prostate cancer, Salvage Stereotactic Reirradiation, Prostatectomy, Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy, Local Recurrence in the Prostatic Bed, PSMA PET-CT, urethro-vesical anastomosis, stereotactic body radiotherapy (SBRT), prostate cancer survival, REPAIR GETUG P16 study, NCT04536805 study.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Incontinence Costs European Society over 40 Billion Euros per Year - 6 month(s) ago
economic burden of urinary incontinence, cost of continence care, 55-60 million Europeans suffer from continence health problems, European Association of Urology, EU Continence Health Summit.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
Research from @CedarsSinai demonstrates that loss of the Y chromosome in cancer could actively drive tumor growth by altering T cell function and allowing cancer to evade the immune system. #ReadNow on UroToday > https://t.co/ajzLEN1cXx @Dan_Theodorescu @RichardKenSuzu1 https://t.co/wg2juziomk